Incidence of pancreas graft thrombosis using low-molecular-weight heparin

Clinical Transplantation

Volumn 23, Issue 3, 2009, Pages 407-414

  Schenker, Peter ^a   Vonend, Oliver ^b   Ertas, Neslihan ^a   Wunsch, Andreas ^a   Schaeffer, Michael ^a   Rump, Lars Christian ^b   Viebahn, Richard ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Graft survival; Graft thrombosis; Kidney transplantation; Low molecular weight heparin; Pancreas transplantation; Simultaneous pancreas; Surgical complications

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX; NADROPARIN;

ADULT; ARTICLE; BLEEDING; CEREBROVASCULAR DISEASE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; LAPAROTOMY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; PANCREAS GRAFT THROMBOSIS; PANCREAS TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBECTOMY; THROMBOSIS; VASCULAR GRAFT THROMBOSIS;

ADULT; ANTICOAGULANTS; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 66849089431     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00911.x     Document Type: Article

References (41)

1. Wullstein C, Woeste G, Zapletal C, Dette K, Bechstein WO. Simultaneous pancreas-kidney transplantation in patients with antiphospholipid syndrome. Transplantation 2003: 75: 562.
2. Troppmann C, Gruessner AC, Dunn DL, Sutherland DE, Gruessner RW. Surgical complications requiring early relaparotomy after pancreas transplantation: A multivariate risk factor and economic impact analysis of the cyclosporine era. Ann Surg 1998: 227: 255.
3. Fischereder M, Gohring P, Schneeberger H et al. Early loss of renal transplants in patients with thrombophilia. Transplantation 1998: 65: 936.
4. Penny MJ, Nankivell BJ, Disney AP, Byth K, Chapman JR. Renal graft thrombosis. A survey of 134 consecutive cases. Transplantation 1994: 58: 565.
5. Gruessner AC, Sutherland DE. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin Transplant 2005: 19: 433.
6. Sollinger HW, Odorico JS, Knechtle SJ, D' Alessandro AM, Kalayoglu M, Pirsch JD. Experience with 500 simultaneous pancreas-kidney transplants. Ann Surg 1998: 228: 284.
7. Troppmann C, Gruessner AC, Benedetti E et al. Vascular graft thrombosis after pancreatic transplantation: Univariate and multivariate operative and nonoperative risk factor analysis. J Am Coll Surg 1996: 182: 285.
8. Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DE. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000: 231: 269.
9. Fertmann JM, Wimmer CD, Arbogast HP et al. Single-shot antithrombin in human pancreas-kidney transplantation: Reduction of reperfusion pancreatitis and prevention of graft thrombosis. Transpl Int 2006: 19: 458.
10. Hopt UT, Busing M, Schareck W et al. Prevention of early postoperative graft thrombosis in pancreatic transplantation. Transplant Proc 1993: 25: 2607.
11. Nader A, Busing M, Blumenstock I, Heimburger N, Jochum M, Hopt UT. Coagulation disorders after reperfusion of pancreatic allografts. Transplant Proc 1993: 25: 1174.
12. Burke GW III, Ciancio G, Figueiro J et al. Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy. Clin Transplant 2004: 18: 423.
13. Sollinger HW. Pancreatic transplantation and vascular graft thrombosis. J Am Coll Surg 1996: 182: 362.
14. Vaidya A, Muthusamy AS, Hadjianastassiou VG et al. Simultaneous pancreas-kidney transplantation: To anticoagulate or not? Is that a question? Clin Transplant 2007: 21: 554.
15. Levine M, Gent M, Hirsh J et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996: 334: 677.
16. Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 1999: 130: 800.
17. Green B, Greenwood M, Saltissi D et al. Dosing strategy for enoxaparin in patients with renal impairment presenting with acute coronary syndromes. Br J Clin Pharmacol 2005: 59: 281.
18. Quinlan DJ, Mc Quillan A, Eikelboom JW. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: A meta-analysis of randomized, controlled trials. Ann Intern Med 2004: 140: 175.
19. Lim W, Dentali F, Eikelboom JW, Crowther MA. Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 2006: 144: 673.
20. Schäffer M, Wunsch A, Michalski S, Traska T, Schenker P, Viebahn R. Morbidity and mortality of kidney and pancreas transplantation. Analysis of 810 transplantations at one center. Dtsch Med Wochenschr 2007: 132: 2318.
21. Steurer W, Bonatti H, Obrist P et al. Incidence of intraabdominal infection in a consecutive series of 40 enteric-drained pancreas transplants with FK506 and MMF immunosuppression. Transpl Int 2000: 13(Suppl 1): S195.
22. Steurer W, Malaise J, Mark W, Koenigsrainer A, Margreiter R. Spectrum of surgical complications after simultaneous pancreas-kidney transplantation in a prospectively randomized study of two immunosuppressive protocols. Nephrol Dial Transplant 2005: 20(Suppl 2): ii54.
23. Gruessner RW, Sutherland DE, Troppmann C et al. The surgical risk of pancreas transplantation in the cyclosporine era: An overview. J Am Coll Surg 1997: 185: 128.
24. Kin S, Tamura K, Nagami H, Teramoto M, Nakase A. The effect of a distal splenic arteriovenous fistula on tissue blood flow in the pancreatic segment. Transplant Proc 1989: 21: 2812.
25. Calne RY, Mc Master P, Rolles K, Duffy TJ. Technical observations in segmental pancreas allografting: Observations on pancreatic blood flow. Transplant Proc 1980: 12(4 Suppl 2): 51.
26. Witzigmann H, Ludwig S, Armann B et al. Endothelin(A) receptor blockade reduces ischemia/reperfusion injury in pig pancreas transplantation. Ann Surg 2003: 238: 264.
27. Hackert T, Werner J, Uhl W, Gebhard MM, Buchler MW, Schmidt J. Reduction of ischemia/reperfusion injury by antithrombin III after experimental pancreas transplantation. Am J Surg 2005: 189: 92.
28. Hoffmann TF, Uhl E, Messmer K. Protective effect of the somatostatin analogue octreotide in ischemia/reperfusion-induced acute pancreatitis in rats. Pancreas 1996: 12: 286.
29. Klar E, Foitzik T, Buhr H, Messmer K, Herfarth C. Isovolemic hemodilution with dextran 60 as treatment of pancreatic ischemia in acute pancreatitis. Clinical practicability of an experimental concept. Ann Surg 1993: 217: 369.
30. Vollmar B, Janata J, Yamauchi JI, Menger MD. Attenuation of microvascular reperfusion injury in rat pancreas transplantation by L-arginine. Transplantation 1999: 67: 950.
31. Schenker P, Wunsch A, Ertas N et al. Long-term results after simultaneous pancreas-kidney transplantation using donors aged 45years or older. Transplant Proc 2008: 40: 923.
32. Carr ME. Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001: 15: 44.
33. Miller GJ. Hyperlipidaemia and hypercoagulability. Prog Lipid Res 1993: 32: 61.
34. Bynon JS, Stratta RJ, Taylor RJ, Lowell JA, Cattral M. Vascular reconstruction in 105 consecutive pancreas transplants. Transplant Proc 1993: 25: 3288.
35. Colwell JA, Nesto RW. The platelet in diabetes: Focus on prevention of ischemic events. Diabetes Care 2003: 26: 2181.
36. Colwell JA. Aspirin therapy in diabetes. Diabetes Care 2003: 26(Suppl 1): S87.
37. Bendetowicz AV, Beguin S, Caplain H, Hemker HC. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin - a three way cross over study in human volunteers. Thromb Haemost 1994: 71: 305.
38. Palm M, Mattsson C. Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance. Thromb Haemost 1987: 58: 932.
39. Wiemer J, Winkler K, Baumstark M, Marz W, Scherberich JE. Influence of low molecular weight heparin compared to conventional heparin for anticoagulation during haemodialysis on low density lipoprotein subclasses. Nephrol Dial Transplant 2002: 17: 2231.
40. Bergqvist D, Burmark US, Frisell J et al. Low molecular weight heparin once daily compared with conventional low-dose heparin twice daily. A prospective double-blind multicentre trial on prevention of postoperative thrombosis. Br J Surg 1986: 73: 204.
41. Koller M, Schoch U, Buchmann P, Largiader F, Von Felten A, Frick PG. Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin. Thromb Haemost 1986: 56: 243.